Received Oct 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | L7L55 | — |
Menveo 1 vial expired dose administration (less than 30 days since expiration); This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 12-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number L7L55, expiry date 30-SEP-2025) for prophylaxis. On 13-OCT-2025, the patient received Menveo. On 13-OCT-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Menveo 1 vial expired dose administration (less than 30 days since expiration)). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 14-OCT-2025 The pharmacist asking how to proceed after administering an expired dose of Menveo 1 vial (less than 30 days since expiration). Patient initials and date of birth unknown by the healthcare professional during the call, but mentioned she could get them later on the same day, thus case number was provided in order for her to contact MI again and provide those details.